Comparable stake leader
TardiMed Sciences LLC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001504167.
Comparable stake leader
TardiMed Sciences LLC
Disclosed value leader
TardiMed Sciences LLC
Comparable rows
0/9
Latest evidence
20 Aug 2023
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
0 of 9 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| TardiMed Sciences LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$5,715,456
3,508,567 shares
|
— | 02 Sep 2021 |
| John Koconis |
3/4/5
CEO & Chairman
|
—
class O/S missing
|
$115,309
70,785 shares
|
— | 20 Aug 2023 |
| Zachary Rome |
3/4/5
Director
|
—
class O/S missing
|
$97,245
59,696 shares
|
— | 04 Mar 2022 |
| Alan Mendelsohn |
3/4/5
EVP & CMO
|
—
class O/S missing
|
$57,719
35,432 shares
|
— | 20 Aug 2023 |
| Joseph Lucchese |
3/4/5
EVP & CFO
|
—
class O/S missing
|
$57,329
35,193 shares
|
— | 20 Aug 2023 |
| Edward J. Sitar |
3/4/5
Director
|
—
mixed-class rows
|
$18,126
16,454 shares
mixed-class rows
|
— | 15 Apr 2023 |
| David E. Cohen |
3/4/5
Director
|
—
mixed-class rows
|
$9,937
10,200 shares
mixed-class rows
|
— | 15 Apr 2023 |
| Gianluca Pirozzi |
3/4/5
Director
|
—
mixed-class rows
|
$9,937
10,200 shares
mixed-class rows
|
— | 15 Apr 2023 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 19 Jun 2025.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Showing 1-9 of 9 reporting-owner rows connected to TREX WIND-DOWN, INC.. Open a relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| TardiMed Sciences LLC | 10%+ Owner | $5,715,456 | Mixed | 02 Sep 2021 | ||
| John Koconis | CEO & Chairman | $115,309 | Mixed | 20 Aug 2023 | ||
| Zachary Rome | Director | $97,245 | Mixed | 04 Mar 2022 | ||
| Alan Mendelsohn | Evp & Cmo | $57,719 | Mixed | 20 Aug 2023 | ||
| Joseph Lucchese | Evp & Cfo | $57,329 | Mixed | 20 Aug 2023 | ||
| Edward J. Sitar | Director | $18,126 | Mixed | 15 Apr 2023 | ||
| David E. Cohen | Director | $9,937 | Mixed | 15 Apr 2023 | ||
| Gianluca Pirozzi | Director | $9,937 | Mixed | 15 Apr 2023 | ||
| Lubor Gaal | Director | $9,937 | Mixed | 15 Apr 2023 |
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||